AR086259A1 - Procesos para la preparacion de inhibidores del virus de la hepatitis c - Google Patents
Procesos para la preparacion de inhibidores del virus de la hepatitis cInfo
- Publication number
- AR086259A1 AR086259A1 ARP120101561A ARP120101561A AR086259A1 AR 086259 A1 AR086259 A1 AR 086259A1 AR P120101561 A ARP120101561 A AR P120101561A AR P120101561 A ARP120101561 A AR P120101561A AR 086259 A1 AR086259 A1 AR 086259A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- cycloalkyl
- formula
- compound
- hepatitis
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 241000711549 Hepacivirus C Species 0.000 title 1
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 abstract 8
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 abstract 6
- 150000001875 compounds Chemical class 0.000 abstract 4
- 108700012707 hepatitis C virus NS3 Proteins 0.000 abstract 3
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 abstract 2
- GNTDGMZSJNCJKK-UHFFFAOYSA-N divanadium pentaoxide Chemical compound O=[V](=O)O[V](=O)=O GNTDGMZSJNCJKK-UHFFFAOYSA-N 0.000 abstract 2
- WOCIAKWEIIZHES-UHFFFAOYSA-N ruthenium(iv) oxide Chemical compound O=[Ru]=O WOCIAKWEIIZHES-UHFFFAOYSA-N 0.000 abstract 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 abstract 2
- -1 K2CrO4 Chemical compound 0.000 abstract 1
- 239000003054 catalyst Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 230000003647 oxidation Effects 0.000 abstract 1
- 238000007254 oxidation reaction Methods 0.000 abstract 1
- 150000002978 peroxides Chemical class 0.000 abstract 1
- KMUONIBRACKNSN-UHFFFAOYSA-N potassium dichromate Chemical compound [K+].[K+].[O-][Cr](=O)(=O)O[Cr]([O-])(=O)=O KMUONIBRACKNSN-UHFFFAOYSA-N 0.000 abstract 1
- 239000012286 potassium permanganate Substances 0.000 abstract 1
- UMPKMCDVBZFQOK-UHFFFAOYSA-N potassium;iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[K+].[Fe+3] UMPKMCDVBZFQOK-UHFFFAOYSA-N 0.000 abstract 1
- 235000010288 sodium nitrite Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/005—Enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Enzymes And Modification Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Procesos sintéticos útiles en la preparación de compuestos de fórmula (1) que son útiles como inhibidores de la proteasa NS3 del virus de la hepatitis C (VHC) y tienen aplicación en el tratamiento de afecciones causadas por el VHC.Reivindicación 1: Un proceso para preparar un compuesto de fórmula (1), en la que: A y E son independientemente un enlace directo; R1 es -NH(alquilo C1-8); R2 es alquilo C1-8; R3 se selecciona independientemente entre el grupo que consiste en alquilo C1-8, alquil C1-8(cicloalquilo C3-8) y alquil C1-8(cicloalquilo C3-8) sustituido; o cada uno de R4 y R5 se selecciona independientemente entre el grupo que consiste en H, alquilo C1-8, cicloalquilo C3-8, alquil C1-8(cicloalquilo C3-8) y alquil C1-8(cicloalquilo C3-8) sustituido, o R4 y R5 pueden tomarse juntos para formar un cicloalquilo C3-8; R6 y R7 son independientemente metilo; comprendiendo el proceso: hacer reaccionar un compuesto de fórmula (2), en la que A, E, R1, R2, R3, R4, R5, R6 y R7 son como se han definido anteriormente, con un agente de oxidación seleccionado entre el grupo que consiste en KMnO4, NaMnO4, K2FeO4, V2O5, RuO2, NaNO2, CrO3, K2CrO4, K2Cr2O7, H5PV2Mo10O4, peróxidos y PhI(OAc)2, en presencia de al menos un catalizador para producir un compuesto de fórmula (1).
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161482592P | 2011-05-04 | 2011-05-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR086259A1 true AR086259A1 (es) | 2013-12-04 |
Family
ID=47108028
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP120101561A AR086259A1 (es) | 2011-05-04 | 2012-05-03 | Procesos para la preparacion de inhibidores del virus de la hepatitis c |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US20140044759A1 (es) |
| EP (2) | EP2704576A4 (es) |
| JP (2) | JP2014513127A (es) |
| KR (2) | KR20140030169A (es) |
| CN (2) | CN103501608A (es) |
| AR (1) | AR086259A1 (es) |
| AU (2) | AU2012250799A1 (es) |
| BR (2) | BR112013027652A2 (es) |
| CA (2) | CA2833887A1 (es) |
| CO (1) | CO6801768A2 (es) |
| IL (1) | IL228601A0 (es) |
| MX (2) | MX2013012771A (es) |
| RU (2) | RU2013153533A (es) |
| SG (1) | SG194711A1 (es) |
| TW (1) | TW201247668A (es) |
| WO (2) | WO2012151271A1 (es) |
| ZA (1) | ZA201308011B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011014487A1 (en) | 2009-07-30 | 2011-02-03 | Merck Sharp & Dohme Corp. | Hepatitis c virus ns3 protease inhibitors |
| BR112015031979B1 (pt) * | 2013-06-19 | 2022-05-24 | Aicuris Anti-Infective Cures Gmbh | Letermovir, formulação farmacêutica oral sólida, uso de uma formulação farmacêutica oral sólida, e processo para preparar letermovir |
| EP3592732B1 (en) * | 2017-03-07 | 2025-04-09 | Orion Corporation | Manufacture of a crystalline pharmaceutical product |
| US11351149B2 (en) | 2020-09-03 | 2022-06-07 | Pfizer Inc. | Nitrile-containing antiviral compounds |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR044694A1 (es) * | 2003-06-17 | 2005-09-21 | Schering Corp | Proceso y compuestos intermedios para la preparacion de (1r, 2s,5s) - 3 azabiciclo [3,1,0] hexano-2- carboxamida, n- [3- amino-1- (ciclobutilmetil) - 2, 3 - dioxopropil] -3- [ (2s) - 2 - [[ [ 1,1- dimetiletil] amino] carbonilamino] -3,3-dimetil -1- oxobutil]-6,6 dimetilo |
| AR056805A1 (es) * | 2005-11-14 | 2007-10-24 | Schering Corp | Un proceso para oxidacion para la preparcion de n- (3- amino-1- ( ciclobutilmetil) -2,3- dioxopropil ) -3-(n-(( ter-butilamino) carbonil )-3- metil- l- valil) -6,6- dimetil-3- azabiciclo (3.1.0) hexano -2- carboxamida y compuestos ralacionados |
| CN101495095B (zh) * | 2006-04-28 | 2013-05-29 | 默沙东公司 | 通过受控的沉淀来沉淀和分离6,6-二甲基-3-氮杂-双环[3.1.0]己烷-酰胺化合物的方法和含有其的药学制剂 |
| US8420122B2 (en) * | 2006-04-28 | 2013-04-16 | Merck Sharp & Dohme Corp. | Process for the precipitation and isolation of 6,6-dimethyl-3-aza-bicyclo [3.1.0] hexane-amide compounds by controlled precipitation and pharmaceutical formulations containing same |
| ES2439246T3 (es) * | 2006-12-20 | 2014-01-22 | Merck Sharp & Dohme Corp. | Procedimiento de preparación de (1R,2S,5S)-N-[(1S)-3-amino-1-(ciclobutilmetil)-2,3-dioxopropil]-3-[(2S)-2-[[[(1,1-dimetiletil)amino]carbonil]amino]-3,3-dimetil-1-oxobutil]-6,6-dimetil-3-azabiciclo[3.1.0]hexan-2-carboxamida |
| SI2118098T1 (sl) * | 2007-02-01 | 2015-01-30 | Janssen R&D Ireland | Polimorfne oblike makrocikličnega inhibitorja HCV |
| JP4803074B2 (ja) * | 2007-03-06 | 2011-10-26 | 日産化学工業株式会社 | アルコール酸化触媒およびその合成方法 |
| ATE519503T1 (de) * | 2007-09-14 | 2011-08-15 | Schering Corp | Verfahren zur behandlung von patienten mit hepatitis c |
| DE102009000662A1 (de) * | 2009-02-06 | 2010-08-12 | Evonik Degussa Gmbh | Verfahren zur Herstellung von Aldehyden und Ketonen aus primären und sekundären Alkoholen |
-
2012
- 2012-05-02 CN CN201280020032.7A patent/CN103501608A/zh active Pending
- 2012-05-02 AU AU2012250799A patent/AU2012250799A1/en not_active Abandoned
- 2012-05-02 WO PCT/US2012/036112 patent/WO2012151271A1/en not_active Ceased
- 2012-05-02 US US14/114,357 patent/US20140044759A1/en not_active Abandoned
- 2012-05-02 US US14/114,251 patent/US20140058116A1/en not_active Abandoned
- 2012-05-02 KR KR1020137028709A patent/KR20140030169A/ko not_active Withdrawn
- 2012-05-02 SG SG2013080643A patent/SG194711A1/en unknown
- 2012-05-02 KR KR1020137028743A patent/KR20140022855A/ko not_active Withdrawn
- 2012-05-02 CN CN2012800200308A patent/CN103476260A/zh active Pending
- 2012-05-02 EP EP12779558.1A patent/EP2704576A4/en not_active Withdrawn
- 2012-05-02 AU AU2012250811A patent/AU2012250811A1/en not_active Abandoned
- 2012-05-02 MX MX2013012771A patent/MX2013012771A/es unknown
- 2012-05-02 JP JP2014509388A patent/JP2014513127A/ja active Pending
- 2012-05-02 JP JP2014509384A patent/JP2014515764A/ja active Pending
- 2012-05-02 MX MX2013012773A patent/MX2013012773A/es unknown
- 2012-05-02 RU RU2013153533/04A patent/RU2013153533A/ru not_active Application Discontinuation
- 2012-05-02 BR BR112013027652A patent/BR112013027652A2/pt not_active IP Right Cessation
- 2012-05-02 CA CA2833887A patent/CA2833887A1/en not_active Abandoned
- 2012-05-02 WO PCT/US2012/036131 patent/WO2012151283A1/en not_active Ceased
- 2012-05-02 CA CA2832869A patent/CA2832869A1/en not_active Abandoned
- 2012-05-02 EP EP12779536.7A patent/EP2704570A4/en not_active Withdrawn
- 2012-05-02 RU RU2013153588/15A patent/RU2013153588A/ru unknown
- 2012-05-02 BR BR112013027642A patent/BR112013027642A2/pt not_active IP Right Cessation
- 2012-05-03 AR ARP120101561A patent/AR086259A1/es not_active Application Discontinuation
- 2012-05-04 TW TW101116053A patent/TW201247668A/zh unknown
-
2013
- 2013-09-29 IL IL228601A patent/IL228601A0/en unknown
- 2013-10-29 ZA ZA2013/08011A patent/ZA201308011B/en unknown
- 2013-11-01 CO CO13259875A patent/CO6801768A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2832869A1 (en) | 2012-11-08 |
| BR112013027652A2 (pt) | 2016-07-26 |
| MX2013012773A (es) | 2013-11-21 |
| SG194711A1 (en) | 2013-12-30 |
| WO2012151271A1 (en) | 2012-11-08 |
| MX2013012771A (es) | 2013-11-21 |
| KR20140022855A (ko) | 2014-02-25 |
| EP2704576A4 (en) | 2014-12-10 |
| JP2014515764A (ja) | 2014-07-03 |
| CO6801768A2 (es) | 2013-11-29 |
| AU2012250811A1 (en) | 2013-12-19 |
| US20140044759A1 (en) | 2014-02-13 |
| KR20140030169A (ko) | 2014-03-11 |
| CN103476260A (zh) | 2013-12-25 |
| IL228601A0 (en) | 2013-12-31 |
| RU2013153588A (ru) | 2015-06-10 |
| EP2704570A4 (en) | 2015-02-18 |
| JP2014513127A (ja) | 2014-05-29 |
| WO2012151283A1 (en) | 2012-11-08 |
| EP2704570A1 (en) | 2014-03-12 |
| BR112013027642A2 (pt) | 2016-07-26 |
| CA2833887A1 (en) | 2012-11-08 |
| EP2704576A1 (en) | 2014-03-12 |
| TW201247668A (en) | 2012-12-01 |
| US20140058116A1 (en) | 2014-02-27 |
| ZA201308011B (en) | 2015-05-27 |
| CN103501608A (zh) | 2014-01-08 |
| AU2012250799A1 (en) | 2013-10-10 |
| RU2013153533A (ru) | 2015-06-10 |
| NZ617300A (en) | 2015-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20121118A1 (es) | Compuestos de haloalquil heteroaril benzamida | |
| CO6361922A2 (es) | Inhibidores del virus de la hepatitis c | |
| AR075332A1 (es) | Dionas ciclicas como herbicidas | |
| AR086019A1 (es) | COMPUESTOS DE PIRROLO SULFONAMIDA PARA MODULACION DE LA ACTIVIDAD DEL RECEPTOR HUERFANO g RELACIONADO AL RECEPTOR NUCLEAR HUERFANO RAR (RORg, NR1F3) Y PARA EL TRATAMIENTO DE ENFERMEDADES INFLAMATORIAS Y AUTOINMUNES CRONICAS | |
| PE20120995A1 (es) | Analogos de carba-nucleosidos sustituidos con 2'-fluoro para tratamiento antiviral | |
| PE20091103A1 (es) | Inhibidores de la polimerasa virica | |
| UY35641A (es) | PROCEDIMIENTO DE SÍNTESIS PARA PREPARAR ANÁLOGOS MACROCÍCLICOS C1-CETO DE HALICONDRINA B, E INTERMEDIARIOS ÚTILES INCLUYENDO INTERMEDIARIOS CONTENIENDO GRUPOS ?SO2-(p-TOLILO) | |
| AR079226A1 (es) | Espiroindolinona- pirrolidinas, procesos de preparacion y uso de los mismos para el tratamiento y profilaxis del cancer | |
| PE20130010A1 (es) | Derivado de 1,3,4,8-tetrahidro-2h-pirido[1,2-a]pirazina como inhibidor de la integrasa del vih | |
| PE20160200A1 (es) | Inhibidores de bromodominios | |
| PE20171341A1 (es) | Compuestos de pirazina para el tratamiento de enfermedades infecciosas | |
| CO6561783A2 (es) | Inhibidores del virus flaviviridae | |
| UA116087C2 (uk) | Композиція для лікування вірусу гепатиту c | |
| UY29704A1 (es) | Inhibidores macrociclicos del virus de la hepatitis c | |
| CO6420390A2 (es) | Inhibidores de la replicación del virus de la hepatitis c. | |
| UY35155A (es) | Derivados cíclicos de nucleósidos y usos de los mismos | |
| UY32325A (es) | Inhibidores de ns3 proteasa del vhc | |
| CO6541557A2 (es) | Inhibidores del virus de hepatitis c | |
| CO2017001178A2 (es) | Derivado de piridona que tiene un grupo tetrahidropiranil metilo | |
| PE20141041A1 (es) | Compuestos, metodos y formulaciones parasiticidas | |
| WO2013074386A3 (en) | Hcv ns3 protease inhibitors | |
| MX362060B (es) | Compuestos antivirales inhibidores del virus de hepatitis c (vhc) ns5b. | |
| PE20120937A1 (es) | Compuestos derivados de quinolina y quinoxalina como agentes antivirales | |
| PE20142452A1 (es) | AMIDAS CICLICAS COMO INHIBIDORES DE MetAP-2 | |
| PE20151718A1 (es) | Compuestos piridinilpirazoloquinolina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |